Stereotactic body radiation therapy (SBRT) for metastatic renal cell carcinoma: A multi-institutional experience.
Year: 2020
Type: article
Abstract: SBRT was well-tolerated with promising LC. Both KPS and osseous metastatic disease should be considered in determining which patients with mRCC may preferentially benefit from SBRT.
Source: Europe PMC (PubMed Central)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3080110419
